LifeMD, Inc. Securities Lawsuit Investigation

Shamis & Gentile P.A., one of the nation's premier class action law firms specializing in securities fraud cases, is investigating potential claims against LifeMD, Inc. (LFMD).

If you purchased or held LifeMD, Inc. securities between May 7, 2025 and August 5, 2025 and suffered losses more than $25,000, you may be eligible to join this class action lawsuit and seek compensation.

About LifeMD, Inc.

LifeMD is a telehealth company operating in the health, wellness, and fitness sector. LifeMD provides virtual access to primary and specialized healthcare providers.

LifeMD’s stock is traded on the NASDAQ under the ticker symbol LFMD, and the company is headquartered in New York, NY.

The Allegations

The securities class action lawsuit alleges that LifeMD and certain executives made materially false and misleading statements to investors during the class period from May 7, 2025 to August 5, 2025. According to the complaint, the company is accused of overstating its competitive position and business prospects, and of raising its 2025 financial guidance without properly accounting for rising customer acquisition costs, especially in its RexMD segment and for obesity drugs like Wegovy and Zepbound.

The complaint further alleges that LifeMD’s leadership failed to disclose these rising costs and other headwinds, misleading investors about the company’s financial outlook. When LifeMD later revised its guidance downward on August 5, 2025, citing these very issues, the stock price fell sharply by 44.8%, dropping $5.31 per share, and closing at $6.53 on August 6, 2025.

Important Dates

• Class period: May 7, 2025 to August 5, 2025
• Lead plaintiff deadline: October 27, 2025
• Complaint filed: August 27, 2025

Your Rights and Next Steps

If you purchased or otherwise acquired LifeMD securities during the class period, you may have the right to participate in this class action lawsuit. Investors who suffered financial losses as a result of the alleged securities fraud can seek to recover their damages by joining the class.

You do not need to take any action to remain a passive member of the class; however, if you wish to be appointed as the lead plaintiff, the representative party who acts on behalf of all class members, you must file a motion with the court by October 27, 2025. The lead plaintiff plays an important role in directing the litigation and negotiating potential settlements.

Lawyers are ready to help you understand your rights, guide you through the process, and answer any questions you may have about your eligibility. Even if you are unsure about your losses or whether you qualify, it is beneficial to reach out and get more information.

You May Be Entitled to Compensation

If you purchased LifeMD securities between May 7, 2025 and August 5, 2025, and experienced financial losses, you may be eligible to recover compensation through this class action lawsuit. The process is straightforward, and there is no cost to you unless there is a recovery.

To find out if you qualify and to take the next step, complete the form below. Lawyers are ready to help you pursue your potential claim.